Clinical Trials Browser

Phase 2 × INDUSTRY × 5-fluoropentyl-2-methylmalonic acid × Clear all

NCT00696943 2013-02-15

18F ML-10 for Early Detection of Response of Brain Metastases to SRS

Phase 2 Terminated

Brain Neoplasms

NCT00791063 2013-02-13

18F ML-10 for Early Detection of Response of Brain Metastases to WBRT

Phase 2 Completed

Brain Neoplasms

NCT01260480 2010-12-17

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

Phase 2 Unknown

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms

NCT00805636 2010-05-12

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Phase 2 Unknown

Brain Neoplasms